Article
Evaluation of the Dutch BRCA1/2 clinical genetic center referral criteria in an unselected early breast cancer population.
European journal of human genetics : EJHG - 1 May 2015
van den Broek Alexandra J, de Ruiter Karen, van 't Veer Laura J, Tollenaar Rob A E M, van Leeuwen Flora E, Verhoef Senno, Schmidt Marjanka K
Abstract excerpt
In this study, we evaluated the diagnostic value of the Dutch Clinical Genetic Center (CGC) referral guidelines for BRCA1/2 mutation testing in 903 early breast cancer patients, unselected for family history, diagnosed in a cancer hospital before the age of 50 years in 1974-2002; most prevalent Dutch pathogenic BRCA1/2 mutations had been analyzed on coded DNA in a research setting. Forty-nine (5.4%) of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
